Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caribou Biosciences (CRBU) Revenue: 2020-2025

Historic Revenue for Caribou Biosciences (CRBU) over the last 6 years, with Sep 2025 value amounting to $2.2 million.

  • Caribou Biosciences' Revenue rose 8.60% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year decrease of 19.00%. This contributed to the annual value of $10.0 million for FY2024, which is 71.01% down from last year.
  • Per Caribou Biosciences' latest filing, its Revenue stood at $2.2 million for Q3 2025, which was down 17.59% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, Caribou Biosciences' Revenue ranged from a high of $23.7 million in Q3 2023 and a low of $1.5 million during Q2 2021.
  • Moreover, its 3-year median value for Revenue was $2.7 million (2025), whereas its average is $4.7 million.
  • As far as peak fluctuations go, Caribou Biosciences' Revenue soared by 616.38% in 2023, and later plummeted by 91.45% in 2024.
  • Over the past 5 years, Caribou Biosciences' Revenue (Quarterly) stood at $2.6 million in 2021, then skyrocketed by 44.28% to $3.7 million in 2022, then dropped by 3.63% to $3.6 million in 2023, then crashed by 41.62% to $2.1 million in 2024, then rose by 8.60% to $2.2 million in 2025.
  • Its last three reported values are $2.2 million in Q3 2025, $2.7 million for Q2 2025, and $2.4 million during Q1 2025.